{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:29:32Z","timestamp":1792690172119,"version":"4.5.0"},"reference-count":276,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.pharmthera.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,10,12]],"date-time":"2014-10-12T21:01:01Z","timestamp":1413147661000},"page":"132-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":369,"special_numbering":"C","title":["FAK signaling in human cancer as a target for therapeutics"],"prefix":"10.1016","volume":"146","author":[{"given":"Brian Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Timpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2014.10.001_bb0005","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1091\/mbc.E02-05-0295","article-title":"Regulation of focal adhesion kinase by a novel protein inhibitor FIP200","volume":"13","author":"Abbi","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0010","doi-asserted-by":"crossref","first-page":"15442","DOI":"10.1074\/jbc.272.24.15442","article-title":"Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells","volume":"272","author":"Abedi","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0015","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1038\/sj.onc.1202957","article-title":"Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells","volume":"18","author":"Agochiya","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0020","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1128\/MCB.22.20.7015-7023.2002","article-title":"v-Crk activates the phosphoinositide 3-kinase\/AKT pathway by utilizing focal adhesion kinase and H-Ras","volume":"22","author":"Akagi","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2407-14-237","article-title":"Tumour-associated endothelial-FAK correlated with molecular sub-type and prognostic factors in invasive breast cancer","volume":"14","author":"Alexopoulou","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0025","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0030","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1083\/jcb.149.3.741","article-title":"Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase","volume":"149","author":"Almeida","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.devcel.2010.07.015","article-title":"Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt\/c-Myc signaling","volume":"19","author":"Ashton","year":"2010","journal-title":"Dev Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0050","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ceb.2005.08.007","article-title":"Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition","volume":"17","author":"Avizienyte","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0055","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ncb829","article-title":"Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling","volume":"4","author":"Avizienyte","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0060","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4161\/cbt.8.9.8246","article-title":"Sunitinib and PF-562,271 (FAK\/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model","volume":"8","author":"Bagi","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0065","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/cncr.23429","article-title":"Dual focal adhesion kinase\/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases","volume":"112","author":"Bagi","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0070","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/0008-5472.CAN-08-3937","article-title":"Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis","volume":"69","author":"Barbero","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1097-2765(02)00776-1","article-title":"Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis","volume":"11","author":"Basu","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/07357900701577475","article-title":"TAE226 inhibits human neuroblastoma cell survival","volume":"26","author":"Beierle","year":"2008","journal-title":"Cancer Investig"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0085","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/MCB.13.8.4648","article-title":"Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts","volume":"13","author":"Birge","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2014.10.001_bb0090","article-title":"Enhancing anti-angiogenic therapy by blocking focal adhesion kinase","volume":"71","author":"Bottsford-Miller","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0095","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/jcp.21096","article-title":"Fak\/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K\/Akt-1 and MEK\/Erk pathways","volume":"212","author":"Bouchard","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/embj.201386399","article-title":"FAK dimerization controls its kinase-dependent functions at focal adhesions","volume":"33","author":"Brami-Cherrier","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0105","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ncb824","article-title":"Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex","volume":"4","author":"Brugnera","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0110","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.onc.1200827","article-title":"A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer","volume":"14","author":"Brunton","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0120","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.119.4.893","article-title":"Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly","volume":"119","author":"Burridge","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/MCB.01324-07","article-title":"Spatial and temporal regulation of focal adhesion kinase activity in living cells","volume":"28","author":"Cai","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0130","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1128\/MCB.15.2.954","article-title":"Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases","volume":"15","author":"Calalb","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0135","first-page":"2417","article-title":"Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes","volume":"6","author":"Cance","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0140","doi-asserted-by":"crossref","first-page":"pe10","DOI":"10.1126\/scisignal.2004021","article-title":"Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics","volume":"6","author":"Cance","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0145","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1158\/1078-0432.CCR-05-1583","article-title":"Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number","volume":"12","author":"Canel","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0150","doi-asserted-by":"crossref","first-page":"9413","DOI":"10.1158\/0008-5472.CAN-10-1454","article-title":"Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics","volume":"70","author":"Canel","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0155","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.282.5392.1318","article-title":"Regulation of cell death protease caspase-9 by phosphorylation","volume":"282","author":"Cardone","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.lungcan.2006.06.001","article-title":"Up-regulation of focal adhesion kinase in non-small cell lung cancer","volume":"53","author":"Carelli","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0165","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0960-9822(03)00544-X","article-title":"A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src","volume":"13","author":"Carragher","year":"2003","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0170","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1074\/jbc.M109.090746","article-title":"Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK)","volume":"285","author":"Chan","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0175","doi-asserted-by":"crossref","first-page":"26901","DOI":"10.1074\/jbc.274.38.26901","article-title":"Suppression of ultraviolet irradiation-induced apoptosis by overexpression of focal adhesion kinase in Madin\u2013Darby canine kidney cells","volume":"274","author":"Chan","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0180","first-page":"629","article-title":"Clinical significance of FAK expression in human neoplasia","volume":"23","author":"Chatzizacharias","year":"2008","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0185","doi-asserted-by":"crossref","first-page":"26329","DOI":"10.1074\/jbc.271.42.26329","article-title":"Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase","volume":"271","author":"Chen","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0190","doi-asserted-by":"crossref","first-page":"16995","DOI":"10.1074\/jbc.270.28.16995","article-title":"Interaction of focal adhesion kinase with cytoskeletal protein talin","volume":"270","author":"Chen","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0220","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/onc.2010.398","article-title":"Phosphorylation of focal adhesion kinase on tyrosine 194 by Met leads to its activation through relief of autoinhibition","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0195","doi-asserted-by":"crossref","first-page":"25777","DOI":"10.1074\/jbc.273.40.25777","article-title":"Tyrosine phosphorylation of focal adhesion kinase stimulated by hepatocyte growth factor leads to mitogen-activated protein kinase activation","volume":"273","author":"Chen","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0215","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1128\/MCB.02186-05","article-title":"Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion","volume":"26","author":"Chen","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0200","doi-asserted-by":"crossref","first-page":"10148","DOI":"10.1073\/pnas.91.21.10148","article-title":"Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase","volume":"91","author":"Chen","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0210","article-title":"Characterization of a selective focal adhesion kinase (FAK) inhibitor in a panel of glioblastoma cell lines identify rational drug\u2013drug combination strategies","volume":"72","author":"Chen","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0205","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/35074500","article-title":"Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain","volume":"3","author":"Chen","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.devcel.2011.11.002","article-title":"VEGF-induced vascular permeability is mediated by FAK","volume":"22","author":"Chen","year":"2012","journal-title":"Dev Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0230","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.onc.1208099","article-title":"Alternative phospholipase D\/mTOR survival signal in human breast cancer cells","volume":"24","author":"Chen","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0240","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1349-7006.2009.01217.x","article-title":"Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance","volume":"100","author":"Chen","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ijc.25025","article-title":"The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt\/NF-kappaB signaling pathway in colorectal carcinomas","volume":"127","author":"Chen","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0245","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbamcr.2004.03.006","article-title":"Regulation of integrin-mediated cellular responses through assembly of a CAS\/Crk scaffold","volume":"1692","author":"Chodniewicz","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0250","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1083\/jcb.201302131","article-title":"pH sensing by FAK-His58 regulates focal adhesion remodeling","volume":"202","author":"Choi","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.yexcr.2007.09.005","article-title":"TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling","volume":"314","author":"Cicchini","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0260","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrc3724","article-title":"Developments in preclinical cancer imaging: innovating the discovery of therapeutics","volume":"14","author":"Conway","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0265","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1038\/sj.onc.1210498","article-title":"Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1","volume":"26","author":"Cordes","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0270","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1158\/0008-5472.CAN-12-1944","article-title":"High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma","volume":"73","author":"Crompton","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0275","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","article-title":"Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery","volume":"91","author":"Datta","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0280","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1074\/jbc.M409180200","article-title":"p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain","volume":"280","author":"Ding","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0285","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0290","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bbrc.2003.10.060","article-title":"RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity","volume":"311","author":"Duxbury","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0295","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.surg.2003.10.017","article-title":"Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells","volume":"135","author":"Duxbury","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0300","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1091\/mbc.01-12-0584","article-title":"Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake","volume":"13","author":"Edinger","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0305","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1083\/jcb.200109079","article-title":"Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling","volume":"157","author":"Eliceiri","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0310","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification and expansion of the tumorigenic lung cancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0315","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1074\/jbc.M112.420497","article-title":"Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial\u2013mesenchymal transition and mammary cancer stem cell activities in vivo","volume":"288","author":"Fan","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0325","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbrc.2013.11.134","article-title":"Somatic mutational analysis of FAK in breast cancer: a novel gain-of-function mutation due to deletion of exon 33","volume":"443","author":"Fang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0320","doi-asserted-by":"crossref","first-page":"e107134","DOI":"10.1371\/journal.pone.0107134","article-title":"New insights into FAK phosphorylation based on a FAT domain-defective mutation","volume":"9","author":"Fang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0330","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nrm2996","article-title":"The FERM domain: organizing the structure and function of FAK","volume":"11","author":"Frame","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0335","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1242\/jcs.02562","article-title":"Regulating cell migration: calpains make the cut","volume":"118","author":"Franco","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0340","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","article-title":"Tumour-cell invasion and migration: diversity and escape mechanisms","volume":"3","author":"Friedl","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0345","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0955-0674(97)80124-X","article-title":"Integrins and anoikis","volume":"9","author":"Frisch","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0350","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1083\/jcb.134.3.793","article-title":"Control of adhesion-dependent cell survival by focal adhesion kinase","volume":"134","author":"Frisch","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0355","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2004.03.029","article-title":"Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor","volume":"41","author":"Fujii","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0360","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00268-005-0165-z","article-title":"Clinical significance of focal adhesion kinase in resectable pancreatic cancer","volume":"30","author":"Furuyama","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0365","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/A:1023725029589","article-title":"FAK regulates biological processes important for the pathogenesis of cancer","volume":"22","author":"Gabarra-Niecko","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0370","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1158\/1078-0432.CCR-05-1867","article-title":"Weak expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome","volume":"12","author":"Gabriel","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0375","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1158\/0008-5472.CAN-05-1661","article-title":"Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells","volume":"66","author":"Garces","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0380","first-page":"49","article-title":"Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis","volume":"31","author":"Garcia","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0385","first-page":"891","article-title":"Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture","volume":"5","author":"Gates","year":"1994","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0390","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","article-title":"Integrin signaling","volume":"285","author":"Giancotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0395","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1083\/jcb.149.2.431","article-title":"Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization","volume":"149","author":"Gilmore","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0400","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1091\/mbc.7.8.1209","article-title":"Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation","volume":"7","author":"Gilmore","year":"1996","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0410","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2741\/4236","article-title":"Targeting FAK in human cancer: from finding to first clinical trials","volume":"19","author":"Golubovskaya","year":"2014","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0415","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0074-7696(07)63003-4","article-title":"Focal adhesion kinase and p53 signaling in cancer cells","volume":"263","author":"Golubovskaya","year":"2007","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0420","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/ijc.24486","article-title":"FAK overexpression and p53 mutations are highly correlated in human breast cancer","volume":"125","author":"Golubovskaya","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0425","doi-asserted-by":"crossref","first-page":"25008","DOI":"10.1074\/jbc.M414172200","article-title":"Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53","volume":"280","author":"Golubovskaya","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0430","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/mc.20395","article-title":"p53 regulates FAK expression in human tumor cells","volume":"47","author":"Golubovskaya","year":"2008","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0435","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/1471-2407-13-342","article-title":"Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth","volume":"13","author":"Golubovskaya","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0440","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1535-7163.MCT-12-0701","article-title":"Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide","volume":"12","author":"Golubovskaya","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0405","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbaexp.2004.03.002","article-title":"Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites","volume":"1678","author":"Golubovskaya","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0445","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/1871520611313040002","article-title":"A small-molecule inhibitor, 5\u2032-O-tritylthymidine, targets FAK and Mdm-2 interaction, and blocks breast and colon tumorigenesis in vivo","volume":"13","author":"Golubovskaya","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0450","doi-asserted-by":"crossref","first-page":"E3177","DOI":"10.1073\/pnas.1317022111","article-title":"Phosphatidylinositol 4,5-bisphosphate triggers activation of focal adhesion kinase by inducing clustering and conformational changes","volume":"111","author":"Goni","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0027806","article-title":"FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and ratio-resistance in advanced squamous cancer cells","volume":"6","author":"Graham","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0460","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/358690a0","article-title":"Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation","volume":"358","author":"Guan","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0465","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.cell.2006.05.029","article-title":"Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration","volume":"125","author":"Gupton","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0470","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1158\/1078-0432.CCR-05-1728","article-title":"Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells","volume":"11","author":"Halder","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0475","doi-asserted-by":"crossref","first-page":"10976","DOI":"10.1158\/0008-5472.CAN-07-2667","article-title":"Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma","volume":"67","author":"Halder","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0480","doi-asserted-by":"crossref","first-page":"d982","DOI":"10.2741\/1114","article-title":"Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility","volume":"8","author":"Hanks","year":"2003","journal-title":"Front Biosci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0485","doi-asserted-by":"crossref","first-page":"12487","DOI":"10.1074\/jbc.C100760200","article-title":"v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion","volume":"277","author":"Hauck","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0490","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1093\/emboj\/cdf631","article-title":"FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth","volume":"21","author":"Hauck","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0495","first-page":"7079","article-title":"Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells","volume":"61","author":"Hauck","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0500","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4161\/cbt.25185","article-title":"Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy","volume":"14","author":"Heffler","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0505","doi-asserted-by":"crossref","first-page":"9851","DOI":"10.1158\/0008-5472.CAN-05-2172","article-title":"Focal adhesion kinase promotes the aggressive melanoma phenotype","volume":"65","author":"Hess","year":"2005","journal-title":"Cancer Res"},{"issue":"11 Suppl.","key":"10.1016\/j.pharmthera.2014.10.001_bb0510","article-title":"BI 853520, a potent and highly selective inhibitor of protein tyrosine kinase 2 (focal adhesion kinase), shows efficacy in multiple xenograft models of human cancer","volume":"10","author":"Hirt","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0515","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1158\/0008-5472.CAN-10-0911","article-title":"Tyrosine phosphorylation profiling reveals the signaling network characteristics of basal breast cancer cells","volume":"70","author":"Hochgrafe","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0520","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.4161\/cc.8.15.9145","article-title":"A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer","volume":"8","author":"Hochwald","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0525","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cellsig.2006.10.001","article-title":"Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts","volume":"19","author":"Horowitz","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0530","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1083\/jcb.200212114","article-title":"Differential regulation of cell motility and invasion by FAK","volume":"160","author":"Hsia","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0535","first-page":"81","article-title":"Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer","volume":"18","author":"Hsu","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0540","doi-asserted-by":"crossref","first-page":"C1339","DOI":"10.1152\/ajpcell.00144.2006","article-title":"Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways","volume":"292","author":"Huang","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0545","first-page":"2017","article-title":"Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability","volume":"25","author":"Huang","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0550","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/stem.271","article-title":"Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation","volume":"28","author":"Hurt","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0555","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.143.2.547","article-title":"Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis","volume":"143","author":"Ilic","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0560","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/377539a0","article-title":"Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice","volume":"377","author":"Ilic","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0565","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/01.RES.0000055016.36679.23","article-title":"Focal adhesion kinase is required for blood vessel morphogenesis","volume":"92","author":"Ilic","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0570","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1200\/JCO.2011.38.9346","article-title":"Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors","volume":"30","author":"Infante","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0575","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1242\/jcs.020941","article-title":"FAK, PDZ-RhoGEF and ROCKII cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts","volume":"121","author":"Iwanicki","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0580","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1083\/jcb.201307067","article-title":"Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function","volume":"204","author":"Jean","year":"2014","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0595","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.3002","article-title":"Phase I study of PF-04554878, a second-generation focal adhesion kinase (FAK) inhibitor, in patients with advanced solid tumors","volume":"29","author":"Jones","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0585","first-page":"4978","article-title":"Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells","volume":"61","author":"Jones","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0590","first-page":"5688","article-title":"PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK)","volume":"61","author":"Jones","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0600","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ni.2821","article-title":"Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia","volume":"15","author":"Joshi","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0605","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/(SICI)1097-0142(19991015)86:6<1551::AID-CNCR23>3.0.CO;2-P","article-title":"Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma","volume":"86","author":"Judson","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0610","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial\u2013mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0615","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s10495-007-0138-9","article-title":"An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK","volume":"12","author":"Kamarajan","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0620","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.canlet.2008.05.042","article-title":"Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis","volume":"270","author":"Kaneda","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0625","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/jnci\/djt210","article-title":"Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer","volume":"105","author":"Kang","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0630","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1073\/pnas.87.9.3328","article-title":"Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases","volume":"87","author":"Kanner","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0635","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/carcin\/bgq024","article-title":"TMPRSS4 induces invasion and epithelial\u2013mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways","volume":"31","author":"Kim","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0640","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3346\/jkms.2004.19.5.710","article-title":"Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study","volume":"19","author":"Kim","year":"2004","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0645","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/ncomms3020","article-title":"FAK-heterozygous mice display enhanced tumour angiogenesis","volume":"4","author":"Kostourou","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0655","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1021\/jm900159g","article-title":"Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo","volume":"52","author":"Kurenova","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0650","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1128\/MCB.24.10.4361-4371.2004","article-title":"Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein","volume":"24","author":"Kurenova","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0660","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.oraloncology.2012.05.019","article-title":"Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma","volume":"48","author":"Kurio","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0665","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.yexcr.2011.02.008","article-title":"Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo","volume":"317","author":"Kurio","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0670","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/bcr3131","article-title":"Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo","volume":"14","author":"Lahlou","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0675","doi-asserted-by":"crossref","first-page":"20302","DOI":"10.1073\/pnas.0710091104","article-title":"Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression","volume":"104","author":"Lahlou","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0680","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/modpathol.3800424","article-title":"High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype","volume":"18","author":"Lark","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0685","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0092-8674(00)81280-5","article-title":"Cell migration: a physically integrated molecular process","volume":"84","author":"Lauffenburger","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0690","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1083\/jcb.201108078","article-title":"FAK promotes recruitment of talin to nascent adhesions to control cell motility","volume":"196","author":"Lawson","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0695","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1158\/1535-7163.MCT-13-0225-T","article-title":"Phosphoproteomic profiling identifies focal adhesion kinase as a mediator of docetaxel resistance in castrate-resistant prostate cancer","volume":"13","author":"Lee","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0700","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.18632\/oncotarget.732","article-title":"FAK is a critical regulator of neuroblastoma liver metastasis","volume":"3","author":"Lee","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0705","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0710","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.cell.2007.05.041","article-title":"Structural basis for the autoinhibition of focal adhesion kinase","volume":"129","author":"Lietha","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0715","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2007.11.031","article-title":"Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation","volume":"29","author":"Lim","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0725","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1083\/jcb.200708194","article-title":"PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility","volume":"180","author":"Lim","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0720","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.4161\/cc.6367","article-title":"FERM control of FAK function: implications for cancer therapy","volume":"7","author":"Lim","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0735","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/carcin\/bgn026","article-title":"FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells","volume":"29","author":"Liu","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0730","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1158\/1535-7163.MCT-06-0476","article-title":"Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo","volume":"6","author":"Liu","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0740","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1091\/mbc.E02-01-0018","article-title":"The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly","volume":"13","author":"Liu","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0745","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00129039-200412000-00009","article-title":"Focal adhesion kinase overexpression in endometrial neoplasia","volume":"12","author":"Livasy","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0750","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1006\/bbrc.2000.3547","article-title":"Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells","volume":"276","author":"Lobo","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0755","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.molcel.2010.01.004","article-title":"SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration","volume":"37","author":"Long","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0760","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/0008-5472.CAN-08-3078","article-title":"Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem\/progenitor cells","volume":"69","author":"Luo","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0765","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1158\/0008-5472.CAN-13-1351","article-title":"Distinct FAK activities determine progenitor and mammary stem cell characteristics","volume":"73","author":"Luo","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0770","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0960-9822(98)00015-3","article-title":"Scar1 and the related Wiskott\u2013Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2\/3 complex","volume":"8","author":"Machesky","year":"1998","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0775","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2005.09.024","article-title":"Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma","volume":"37","author":"Madan","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0780","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1647","article-title":"The role of focal-adhesion kinase in cancer\u2014a new therapeutic opportunity","volume":"5","author":"McLean","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0785","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1101\/gad.316304","article-title":"Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression","volume":"18","author":"McLean","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0790","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bjc.6605154","article-title":"Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion","volume":"101","author":"Meng","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0795","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/path.4274","article-title":"Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer","volume":"231","author":"Menon","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0800","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/35000008","article-title":"Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation","volume":"2","author":"Miao","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0805","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1242\/jcs.135509","article-title":"A non-canonical role for Rgnef in promoting integrin-stimulated focal adhesion kinase activation","volume":"126","author":"Miller","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0810","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal adhesion kinase: in command and control of cell motility","volume":"6","author":"Mitra","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0815","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1038\/sj.onc.1209588","article-title":"Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors","volume":"25","author":"Mitra","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0820","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0825","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/sj.bjc.6601050","article-title":"FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma","volume":"89","author":"Miyazaki","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0830","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.0908428107","article-title":"Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer","volume":"107","author":"Morton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0835","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0092-8674(95)90370-4","article-title":"Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia","volume":"81","author":"Nobes","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0840","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1083\/jcb.144.6.1235","article-title":"Rho GTPases control polarity, protrusion, and adhesion during cell movement","volume":"144","author":"Nobes","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0845","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/jhep.2003.50457","article-title":"PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas","volume":"38","author":"Okamoto","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0855","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/hupa.2003.40","article-title":"Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas","volume":"34","author":"Oktay","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0850","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1083\/jcb.145.7.1461","article-title":"Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle","volume":"145","author":"Oktay","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0860","first-page":"2752","article-title":"Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors","volume":"55","author":"Owens","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0865","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.284.5415.765","article-title":"A cell's sense of direction","volume":"284","author":"Parent","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0870","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.humpath.2010.06.004","article-title":"Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer","volume":"41","author":"Park","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0875","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1242\/jcs.00373","article-title":"Focal adhesion kinase: the first ten years","volume":"116","author":"Parsons","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0880","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1083\/jcb.200510062","article-title":"An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling","volume":"174","author":"Pirone","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0885","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1038\/sj.onc.1208080","article-title":"The interplay between Src and integrins in normal and tumor biology","volume":"23","author":"Playford","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0890","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1073\/pnas.92.23.10678","article-title":"Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas","volume":"92","author":"Polte","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0895","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jcb.240550113","article-title":"Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II","volume":"55","author":"Polte","year":"1994","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0900","doi-asserted-by":"crossref","first-page":"37686","DOI":"10.1074\/jbc.M106175200","article-title":"Ezrin interacts with focal adhesion kinase and induces its activation independently of cell-matrix adhesion","volume":"276","author":"Poullet","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0905","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2353\/ajpath.2008.080308","article-title":"Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer","volume":"173","author":"Provenzano","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0910","first-page":"252","article-title":"Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling","volume":"119","author":"Pylayeva","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0915","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1073\/pnas.070552297","article-title":"The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton","volume":"97","author":"Randazzo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0920","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0021-9258(17)42406-9","article-title":"Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin","volume":"269","author":"Rankin","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0925","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10555-005-5134-3","article-title":"Clinging to life: cell to matrix adhesion and cell survival","volume":"24","author":"Reddig","year":"2005","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0930","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1083\/jcb.152.5.971","article-title":"Regulation of CDC42 GTPase by proline-rich tyrosine kinase 2 interacting with PSGAP, a novel pleckstrin homology and Src homology 3 domain containing rhoGAP protein","volume":"152","author":"Ren","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0935","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1128\/MCB.17.12.6906","article-title":"Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation","volume":"17","author":"Richardson","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0940","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/carcin\/bgs284","article-title":"Focal adhesion kinase is required for beta-catenin-induced mobilization of epidermal stem cells","volume":"33","author":"Ridgway","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0945","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1092053","article-title":"Cell migration: integrating signals from front to back","volume":"302","author":"Ridley","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0950","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/0008-5472.CAN-07-5155","article-title":"Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271","volume":"68","author":"Roberts","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0955","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1158\/1940-6207.CAPR-10-0338","article-title":"Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy","volume":"4","author":"Rodrigo","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0960","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archotol.133.2.145","article-title":"Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer","volume":"133","author":"Rodrigo","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0965","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1091\/mbc.5.3.349","article-title":"Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells","volume":"5","author":"Romer","year":"1994","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0970","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/bbrc.1996.0978","article-title":"Phosphatidylinositol 3-kinase activity is required for the activation process of focal adhesion kinase by platelet-derived growth factor","volume":"224","author":"Saito","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0975","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1158\/1535-7163.MCT-08-0884","article-title":"Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor","volume":"8","author":"Sakurama","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0980","doi-asserted-by":"crossref","first-page":"17788","DOI":"10.1074\/jbc.M100984200","article-title":"Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397","volume":"276","author":"Salazar","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0985","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ccr.2011.05.008","article-title":"Actomyosin-mediated cellular tension drives increased tissue stiffness and beta-catenin activation to induce epidermal hyperplasia and tumor growth","volume":"19","author":"Samuel","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0990","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ncb2386","article-title":"Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling","volume":"14","author":"Sandilands","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb0995","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/embor.2012.92","article-title":"Src-dependent autophagic degradation of Ret in FAK-signalling-defective cancer cells","volume":"13","author":"Sandilands","year":"2012","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1000","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1242\/jcs.045112","article-title":"Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions","volume":"123","author":"Schaller","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1005","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1073\/pnas.89.11.5192","article-title":"pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions","volume":"89","author":"Schaller","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1010","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/MCB.14.3.1680","article-title":"Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src","volume":"14","author":"Schaller","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-2187-3-1","article-title":"Multiple paxillin binding sites regulate FAK function","volume":"3","author":"Scheswohl","year":"2008","journal-title":"J Mol Signal"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1020","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/MCB.17.3.1702","article-title":"Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins","volume":"17","author":"Schlaepfer","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1025","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/372786a0","article-title":"Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase","volume":"372","author":"Schlaepfer","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0079-6107(98)00052-2","article-title":"Signaling through focal adhesion kinase","volume":"71","author":"Schlaepfer","year":"1999","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1035","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/cncr.10992","article-title":"Elevated focal adhesion kinase expression facilitates oral tumor cell invasion","volume":"95","author":"Schneider","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1517\/13543784.2010.489548","article-title":"Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer","volume":"19","author":"Schultze","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1045","doi-asserted-by":"crossref","first-page":"25533","DOI":"10.1074\/jbc.273.40.25533","article-title":"Control of cell cycle progression by fibronectin matrix architecture","volume":"273","author":"Sechler","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1050","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ncomms1414","article-title":"Detection of focal adhesion kinase activation at membrane microdomains by fluorescence resonance energy transfer","volume":"2","author":"Seong","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijc.26351","article-title":"The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells","volume":"131","author":"Serrels","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4161\/sgtp.2.1.15137","article-title":"Signaling of the direction-sensing FAK\/RACK1\/PDE4D5 complex to the small GTPase Rap1","volume":"2","author":"Serrels","year":"2011","journal-title":"Small GTPases"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1070","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ncb1626","article-title":"Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2\/3 complex","volume":"9","author":"Serrels","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1060","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/0008-5472.CAN-08-4308","article-title":"Real-time study of E-cadherin and membrane dynamics in living animals: implications for disease modeling and drug development","volume":"69","author":"Serrels","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2014.04.044","article-title":"Analyses of merlin\/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer","volume":"134","author":"Shah","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1080","doi-asserted-by":"crossref","first-page":"237ra268","DOI":"10.1126\/scitranslmed.3008639","article-title":"Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship","volume":"6","author":"Shapiro","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0014-5793(01)02545-5","article-title":"Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts","volume":"499","author":"Shen","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/mc.20297","article-title":"A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth","volume":"46","author":"Shi","year":"2007","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1095","first-page":"900","article-title":"Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells","volume":"58","author":"Shibata","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35010517","article-title":"FAK integrates growth-factor and integrin signals to promote cell migration","volume":"2","author":"Sieg","year":"2000","journal-title":"Nat Cell Biol"},{"issue":"Pt 16","key":"10.1016\/j.pharmthera.2014.10.001_bb1105","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1242\/jcs.112.16.2677","article-title":"Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration","volume":"112","author":"Sieg","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1110","doi-asserted-by":"crossref","first-page":"14845","DOI":"10.1074\/jbc.M606695200","article-title":"Cellular characterization of a novel focal adhesion kinase inhibitor","volume":"282","author":"Slack-Davis","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1115","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1006\/bbrc.1997.7895","article-title":"A suppressive role of p125FAK protein tyrosine kinase in hydrogen peroxide-induced apoptosis of T98G cells","volume":"241","author":"Sonoda","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1120","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1074\/jbc.275.21.16309","article-title":"Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60","volume":"275","author":"Sonoda","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1125","doi-asserted-by":"crossref","first-page":"10566","DOI":"10.1074\/jbc.274.15.10566","article-title":"FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line","volume":"274","author":"Sonoda","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1130","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI40802","article-title":"Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis","volume":"120","author":"Sood","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1135","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0002-9440(10)63370-6","article-title":"Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion","volume":"165","author":"Sood","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1140","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.3000","article-title":"Phase I clinical and pharmacologic study of the focal adhesion kinase (FAK) inhibitor GSK2256098 in pts with advanced solid tumors","volume":"30","author":"Soria","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1145","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1158\/1535-7163.MCT-11-0261","article-title":"Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment","volume":"10","author":"Stokes","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1150","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4161\/cbt.28882","article-title":"Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer","volume":"15","author":"Stone","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1155","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3748\/wjg.v8.i4.613","article-title":"Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance","volume":"8","author":"Su","year":"2002","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1083\/jcb.200308011","article-title":"Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility","volume":"165","author":"Subauste","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1165","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"Sulzmaier","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4161\/cbt.10.1.11993","article-title":"Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models","volume":"10","author":"Sun","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1175","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.182.4.1089","article-title":"Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK","volume":"182","author":"Tachibana","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1180","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbagen.2006.11.011","article-title":"Focal adhesion kinase determines the fate of death or survival of cells in response to TNFalpha in the presence of actinomycin D","volume":"1770","author":"Takahashi","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1185","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cub.2012.11.059","article-title":"Loss of Scar\/WAVE complex promotes N-WASP- and FAK-dependent invasion","volume":"23","author":"Tang","year":"2013","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1190","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4161\/cbt.9.10.11434","article-title":"PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments","volume":"9","author":"Tanjoni","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1195","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/emmm.201000106","article-title":"Endothelial FAK is required for tumour angiogenesis","volume":"2","author":"Tavora","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature13541","article-title":"Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy","volume":"514","author":"Tavora","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1205","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1128\/MCB.21.5.1565-1572.2001","article-title":"Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells","volume":"21","author":"Taylor","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1210","first-page":"BR221","article-title":"Focal adhesion kinase (FAK) immunocytochemical expression in breast ductal invasive carcinoma (DIC): correlation with clinicopathological parameters and tumor proliferative capacity","volume":"15","author":"Theocharis","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial\u2013mesenchymal transitions","volume":"7","author":"Thiery","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1220","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1242\/jcs.02380","article-title":"Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells","volume":"118","author":"Tilghman","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1225","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/S0960-9822(01)00583-8","article-title":"Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity","volume":"11","author":"Timpson","year":"2001","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1230","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1242\/jcs.046870","article-title":"A FAK\u2013p120RasGAP\u2013p190RhoGAP complex regulates polarity in migrating cells","volume":"122","author":"Tomar","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1235","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ceb.2009.05.006","article-title":"Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility","volume":"21","author":"Tomar","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1240","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W","article-title":"Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma","volume":"68","author":"Tremblay","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1245","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0960-9822(99)80169-9","article-title":"A unique talin homologue with a villin headpiece-like domain is required for multicellular morphogenesis in Dictyostelium","volume":"9","author":"Tsujioka","year":"1999","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1250","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.4161\/cc.21611","article-title":"Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth","volume":"11","author":"Ucar","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1255","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/1871520611313040009","article-title":"Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo","volume":"13","author":"Ucar","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1260","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1038\/bjc.2014.219","article-title":"Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation","volume":"110","author":"van Miltenburg","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1265","first-page":"203","article-title":"Regulation of angiogenesis via vascular endothelial growth factor receptors","volume":"60","author":"Veikkola","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1270","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"Visvader","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1275","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4161\/cbt.9.10.11433","article-title":"Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models","volume":"9","author":"Walsh","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1280","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1083\/jcb.201105153","article-title":"Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex","volume":"196","author":"Wang","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1285","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10585-012-9562-5","article-title":"Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression","volume":"30","author":"Ward","year":"2013","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1290","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1158\/1078-0432.CCR-07-4755","article-title":"Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo","volume":"14","author":"Watanabe","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1295","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ncb1094","article-title":"FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly","volume":"6","author":"Webb","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1300","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jcp.21530","article-title":"Formation of Kv2.1-FAK complex as a mechanism of FAK activation, cell polarization and enhanced motility","volume":"217","author":"Wei","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1305","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0140-6736(93)92881-S","article-title":"Expression of focal adhesion kinase gene and invasive cancer","volume":"342","author":"Weiner","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1310","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.devcel.2005.06.006","article-title":"FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation","volume":"9","author":"Wu","year":"2005","journal-title":"Dev Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1320","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1074\/jbc.M310739200","article-title":"Focal adhesion kinase regulation of N-WASP subcellular localization and function","volume":"279","author":"Wu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-005-9025-9","article-title":"Antisense oligonucleodes targeting the focal adhesion kinase inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human glioma cells","volume":"77","author":"Wu","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1330","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1479-5876-12-136","article-title":"An aberrant spliced transcript of focal adhesion kinase is exclusively expressed in human breast cancer","volume":"12","author":"Yao","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1335","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10549-010-1150-2","article-title":"Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer","volume":"128","author":"Yom","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1345","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1091\/mbc.E09-07-0548","article-title":"Paxillin-kinase-linker tyrosine phosphorylation regulates directional cell migration","volume":"20","author":"Yu","year":"2009","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1340","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/ijc.22207","article-title":"Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase","volume":"119","author":"Yu","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1350","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1083\/jcb.200206049","article-title":"PTP alpha regulates integrin-stimulated FAK autophosphorylation and cytoskeletal rearrangement in cell spreading and migration","volume":"160","author":"Zeng","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1355","doi-asserted-by":"crossref","first-page":"24865","DOI":"10.1074\/jbc.M302381200","article-title":"Direct interaction of focal adhesion kinase with p190RhoGEF","volume":"278","author":"Zhai","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1360","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1091\/mbc.12.12.4066","article-title":"Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression","volume":"12","author":"Zhao","year":"2001","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1365","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1083\/jcb.143.7.1997","article-title":"Regulation of the cell cycle by focal adhesion kinase","volume":"143","author":"Zhao","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1375","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1038\/onc.2012.427","article-title":"Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT","volume":"32","author":"Zheng","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1370","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mc.20590","article-title":"A novel strategy to inhibit FAK and IGF-1R decreases growth of pancreatic cancer xenografts","volume":"49","author":"Zheng","year":"2010","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.pharmthera.2014.10.001_bb1380","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1242\/jcs.030478","article-title":"FAK engages multiple pathways to maintain survival of fibroblasts and epithelia: differential roles for paxillin and p130Cas","volume":"122","author":"Zouq","year":"2009","journal-title":"J Cell Sci"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725814001879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725814001879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T20:41:45Z","timestamp":1717447305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725814001879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":276,"alternative-id":["S0163725814001879"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2014.10.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FAK signaling in human cancer as a target for therapeutics","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}